1 Vector-Based RNAi Market Overview 1.1 Vector-Based RNAi Product Scope 1.2 Vector-Based RNAi Segment by Type 1.2.1 Global Vector-Based RNAi Sales by Type (2016 & 2021 & 2027) 1.2.2 siRNA Design 1.2.3 siRNA Vectors 1.2.4 Custom siRNA Construction 1.3 Vector-Based RNAi Segment by Application 1.3.1 Global Vector-Based RNAi Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospitals 1.3.3 Speciality Clinics 1.4 Vector-Based RNAi Market Estimates and Forecasts (2016-2027) 1.4.1 Global Vector-Based RNAi Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Vector-Based RNAi Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Vector-Based RNAi Price Trends (2016-2027) 2 Vector-Based RNAi Estimates and Forecasts by Region 2.1 Global Vector-Based RNAi Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Vector-Based RNAi Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Vector-Based RNAi Sales Market Share by Region (2016-2021) 2.2.2 Global Vector-Based RNAi Revenue Market Share by Region (2016-2021) 2.3 Global Vector-Based RNAi Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Vector-Based RNAi Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Vector-Based RNAi Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Vector-Based RNAi Estimates and Projections (2016-2027) 2.4.2 Europe Vector-Based RNAi Estimates and Projections (2016-2027) 2.4.3 China Vector-Based RNAi Estimates and Projections (2016-2027) 2.4.4 Japan Vector-Based RNAi Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Vector-Based RNAi Estimates and Projections (2016-2027) 2.4.6 India Vector-Based RNAi Estimates and Projections (2016-2027) 3 Global Vector-Based RNAi Competition Landscape by Players 3.1 Global Top Vector-Based RNAi Players by Sales (2016-2021) 3.2 Global Top Vector-Based RNAi Players by Revenue (2016-2021) 3.3 Global Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vector-Based RNAi as of 2020) 3.4 Global Vector-Based RNAi Average Price by Company (2016-2021) 3.5 Manufacturers Vector-Based RNAi Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Vector-Based RNAi Market Size by Type 4.1 Global Vector-Based RNAi Historic Market Review by Type (2016-2021) 4.1.1 Global Vector-Based RNAi Sales Market Share by Type (2016-2021) 4.1.2 Global Vector-Based RNAi Revenue Market Share by Type (2016-2021) 4.1.3 Global Vector-Based RNAi Price by Type (2016-2021) 4.2 Global Vector-Based RNAi Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Vector-Based RNAi Sales Forecast by Type (2022-2027) 4.2.2 Global Vector-Based RNAi Revenue Forecast by Type (2022-2027) 4.2.3 Global Vector-Based RNAi Price Forecast by Type (2022-2027) 5 Global Vector-Based RNAi Market Size by Application 5.1 Global Vector-Based RNAi Historic Market Review by Application (2016-2021) 5.1.1 Global Vector-Based RNAi Sales Market Share by Application (2016-2021) 5.1.2 Global Vector-Based RNAi Revenue Market Share by Application (2016-2021) 5.1.3 Global Vector-Based RNAi Price by Application (2016-2021) 5.2 Global Vector-Based RNAi Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Vector-Based RNAi Sales Forecast by Application (2022-2027) 5.2.2 Global Vector-Based RNAi Revenue Forecast by Application (2022-2027) 5.2.3 Global Vector-Based RNAi Price Forecast by Application (2022-2027) 6 North America Vector-Based RNAi Market Facts & Figures 6.1 North America Vector-Based RNAi Sales by Company 6.1.1 North America Vector-Based RNAi Sales by Company (2016-2021) 6.1.2 North America Vector-Based RNAi Revenue by Company (2016-2021) 6.2 North America Vector-Based RNAi Sales Breakdown by Type 6.2.1 North America Vector-Based RNAi Sales Breakdown by Type (2016-2021) 6.2.2 North America Vector-Based RNAi Sales Breakdown by Type (2022-2027) 6.3 North America Vector-Based RNAi Sales Breakdown by Application 6.3.1 North America Vector-Based RNAi Sales Breakdown by Application (2016-2021) 6.3.2 North America Vector-Based RNAi Sales Breakdown by Application (2022-2027) 7 Europe Vector-Based RNAi Market Facts & Figures 7.1 Europe Vector-Based RNAi Sales by Company 7.1.1 Europe Vector-Based RNAi Sales by Company (2016-2021) 7.1.2 Europe Vector-Based RNAi Revenue by Company (2016-2021) 7.2 Europe Vector-Based RNAi Sales Breakdown by Type 7.2.1 Europe Vector-Based RNAi Sales Breakdown by Type (2016-2021) 7.2.2 Europe Vector-Based RNAi Sales Breakdown by Type (2022-2027) 7.3 Europe Vector-Based RNAi Sales Breakdown by Application 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027) 8 China Vector-Based RNAi Market Facts & Figures 8.1 China Vector-Based RNAi Sales by Company 8.1.1 China Vector-Based RNAi Sales by Company (2016-2021) 8.1.2 China Vector-Based RNAi Revenue by Company (2016-2021) 8.2 China Vector-Based RNAi Sales Breakdown by Type 8.2.1 China Vector-Based RNAi Sales Breakdown by Type (2016-2021) 8.2.2 China Vector-Based RNAi Sales Breakdown by Type (2022-2027) 8.3 China Vector-Based RNAi Sales Breakdown by Application 8.3.1 China 316 Sales Breakdown by Application (2016-2021) 8.3.2 China 316 Sales Breakdown by Application (2022-2027) 9 Japan Vector-Based RNAi Market Facts & Figures 9.1 Japan Vector-Based RNAi Sales by Company 9.1.1 Japan Vector-Based RNAi Sales by Company (2016-2021) 9.1.2 Japan Vector-Based RNAi Revenue by Company (2016-2021) 9.2 Japan Vector-Based RNAi Sales Breakdown by Type 9.2.1 Japan Vector-Based RNAi Sales Breakdown by Type (2016-2021) 9.2.2 Japan Vector-Based RNAi Sales Breakdown by Type (2022-2027) 9.3 Japan Vector-Based RNAi Sales Breakdown by Application 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Vector-Based RNAi Market Facts & Figures 10.1 Southeast Asia Vector-Based RNAi Sales by Company 10.1.1 Southeast Asia Vector-Based RNAi Sales by Company (2016-2021) 10.1.2 Southeast Asia Vector-Based RNAi Revenue by Company (2016-2021) 10.2 Southeast Asia Vector-Based RNAi Sales Breakdown by Type 10.2.1 Southeast Asia Vector-Based RNAi Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Vector-Based RNAi Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Vector-Based RNAi Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Vector-Based RNAi Market Facts & Figures 11.1 India Vector-Based RNAi Sales by Company 11.1.1 India Vector-Based RNAi Sales by Company (2016-2021) 11.1.2 India Vector-Based RNAi Revenue by Company (2016-2021) 11.2 India Vector-Based RNAi Sales Breakdown by Type 11.2.1 India Vector-Based RNAi Sales Breakdown by Type (2016-2021) 11.2.2 India Vector-Based RNAi Sales Breakdown by Type (2022-2027) 11.3 India Vector-Based RNAi Sales Breakdown by Application 11.3.1 India Vector-Based RNAi Sales Breakdown by Application (2016-2021) 11.3.2 India Vector-Based RNAi Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Vector-Based RNAi Business 12.1 Merck & Co. 12.1.1 Merck & Co. Corporation Information 12.1.2 Merck & Co. Business Overview 12.1.3 Merck & Co. Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Merck & Co. Vector-Based RNAi Products Offered 12.1.5 Merck & Co. Recent Development 12.2 Phio Pharmaceutical 12.2.1 Phio Pharmaceutical Corporation Information 12.2.2 Phio Pharmaceutical Business Overview 12.2.3 Phio Pharmaceutical Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Phio Pharmaceutical Vector-Based RNAi Products Offered 12.2.5 Phio Pharmaceutical Recent Development 12.3 Quark Pharmaceuticals 12.3.1 Quark Pharmaceuticals Corporation Information 12.3.2 Quark Pharmaceuticals Business Overview 12.3.3 Quark Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Quark Pharmaceuticals Vector-Based RNAi Products Offered 12.3.5 Quark Pharmaceuticals Recent Development 12.4 Thermo Fisher Scientific 12.4.1 Thermo Fisher Scientific Corporation Information 12.4.2 Thermo Fisher Scientific Business Overview 12.4.3 Thermo Fisher Scientific Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Thermo Fisher Scientific Vector-Based RNAi Products Offered 12.4.5 Thermo Fisher Scientific Recent Development 12.5 Silence Therapeutics 12.5.1 Silence Therapeutics Corporation Information 12.5.2 Silence Therapeutics Business Overview 12.5.3 Silence Therapeutics Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Silence Therapeutics Vector-Based RNAi Products Offered 12.5.5 Silence Therapeutics Recent Development 12.6 Qiagen NV 12.6.1 Qiagen NV Corporation Information 12.6.2 Qiagen NV Business Overview 12.6.3 Qiagen NV Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Qiagen NV Vector-Based RNAi Products Offered 12.6.5 Qiagen NV Recent Development 12.7 Ionis Pharmaceutical 12.7.1 Ionis Pharmaceutical Corporation Information 12.7.2 Ionis Pharmaceutical Business Overview 12.7.3 Ionis Pharmaceutical Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Ionis Pharmaceutical Vector-Based RNAi Products Offered 12.7.5 Ionis Pharmaceutical Recent Development 12.8 Dicerna Pharmaceuticals 12.8.1 Dicerna Pharmaceuticals Corporation Information 12.8.2 Dicerna Pharmaceuticals Business Overview 12.8.3 Dicerna Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Dicerna Pharmaceuticals Vector-Based RNAi Products Offered 12.8.5 Dicerna Pharmaceuticals Recent Development 12.9 Arrowhead Pharmaceuticals 12.9.1 Arrowhead Pharmaceuticals Corporation Information 12.9.2 Arrowhead Pharmaceuticals Business Overview 12.9.3 Arrowhead Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Arrowhead Pharmaceuticals Vector-Based RNAi Products Offered 12.9.5 Arrowhead Pharmaceuticals Recent Development 12.10 Arcturus Therapeutics 12.10.1 Arcturus Therapeutics Corporation Information 12.10.2 Arcturus Therapeutics Business Overview 12.10.3 Arcturus Therapeutics Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Arcturus Therapeutics Vector-Based RNAi Products Offered 12.10.5 Arcturus Therapeutics Recent Development 12.11 Alnylam Pharmaceuticals 12.11.1 Alnylam Pharmaceuticals Corporation Information 12.11.2 Alnylam Pharmaceuticals Business Overview 12.11.3 Alnylam Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Alnylam Pharmaceuticals Vector-Based RNAi Products Offered 12.11.5 Alnylam Pharmaceuticals Recent Development 13 Vector-Based RNAi Manufacturing Cost Analysis 13.1 Vector-Based RNAi Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Vector-Based RNAi 13.4 Vector-Based RNAi Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Vector-Based RNAi Distributors List 14.3 Vector-Based RNAi Customers 15 Market Dynamics 15.1 Vector-Based RNAi Market Trends 15.2 Vector-Based RNAi Drivers 15.3 Vector-Based RNAi Market Challenges 15.4 Vector-Based RNAi Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Vector-Based RNAi Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Vector-Based RNAi Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Vector-Based RNAi Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Vector-Based RNAi Sales (K Units) by Region (2016-2021) Table 5. Global Vector-Based RNAi Sales Market Share by Region (2016-2021) Table 6. Global Vector-Based RNAi Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Vector-Based RNAi Revenue Share by Region (2016-2021) Table 8. Global Vector-Based RNAi Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Vector-Based RNAi Sales Market Share Forecast by Region (2022-2027) Table 10. Global Vector-Based RNAi Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Vector-Based RNAi Revenue Share Forecast by Region (2022-2027) Table 12. Global Vector-Based RNAi Sales (K Units) of Key Companies (2016-2021) Table 13. Global Vector-Based RNAi Sales Share by Company (2016-2021) Table 14. Global Vector-Based RNAi Revenue (US$ Million) by Company (2016-2021) Table 15. Global Vector-Based RNAi Revenue Share by Company (2016-2021) Table 16. Global Vector-Based RNAi by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vector-Based RNAi as of 2020) Table 17. Global Vector-Based RNAi Average Price (US$/Unit) of Key Company (2016-2021) Table 18. Manufacturers Vector-Based RNAi Manufacturing Sites and Area Served Table 19. Manufacturers Vector-Based RNAi Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Vector-Based RNAi Sales (K Units) by Type (2016-2021) Table 22. Global Vector-Based RNAi Sales Share by Type (2016-2021) Table 23. Global Vector-Based RNAi Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Vector-Based RNAi Price (US$/Unit) by Type (2016-2021) Table 25. Global Vector-Based RNAi Sales Share by Type (2022-2027) Table 26. Global Vector-Based RNAi Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Vector-Based RNAi Revenue Share by Type (2022-2027) Table 28. Global Vector-Based RNAi Price (US$/Unit) by Type (2022-2027) Table 29. Global Vector-Based RNAi Sales (K Units) by Application (2016-2021) Table 30. Global Vector-Based RNAi Sales Share by Application (2016-2021) Table 31. Global Vector-Based RNAi Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Vector-Based RNAi Price (US$/Unit) by Application (2016-2021) Table 33. Global Vector-Based RNAi Sales (K Units) by Application (2022-2027) Table 34. Global Vector-Based RNAi Sales Share by Application (2022-2027) Table 35. Global Vector-Based RNAi Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Vector-Based RNAi Revenue Share by Application (2022-2027) Table 37. Global Vector-Based RNAi Price (US$/Unit) by Application (2022-2027) Table 38. North America Vector-Based RNAi Sales (K Units) by Company (2016-2021) Table 39. North America Vector-Based RNAi Sales Market Share by Company (2016-2021) Table 40. North America Vector-Based RNAi Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Vector-Based RNAi Revenue Market Share by Company (2016-2021) Table 42. North America Vector-Based RNAi Sales by Type (2016-2021) & (K Units) Table 43. North America Vector-Based RNAi Sales Market Share by Type (2016-2021) Table 44. North America Vector-Based RNAi Sales by Type (2022-2027) & (K Units) Table 45. North America Vector-Based RNAi Sales Market Share by Type (2022-2027) Table 46. North America Vector-Based RNAi Sales by Application (2016-2021) & (K Units) Table 47. North America Vector-Based RNAi Sales Market Share by Application (2016-2021) Table 48. North America Vector-Based RNAi Sales by Application (2022-2027) & (K Units) Table 49. North America Vector-Based RNAi Sales Market Share by Application (2022-2027) Table 50. Europe Vector-Based RNAi Sales (K Units) by Company (2016-2021) Table 51. Europe Vector-Based RNAi Sales Market Share by Company (2016-2021) Table 52. Europe Vector-Based RNAi Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Vector-Based RNAi Revenue Market Share by Company (2016-2021) Table 54. Europe Vector-Based RNAi Sales by Type (2016-2021) & (K Units) Table 55. Europe Vector-Based RNAi Sales Market Share by Type (2016-2021) Table 56. Europe Vector-Based RNAi Sales by Type (2022-2027) & (K Units) Table 57. Europe Vector-Based RNAi Sales Market Share by Type (2022-2027) Table 58. Europe Vector-Based RNAi Sales by Application (2016-2021) & (K Units) Table 59. Europe Vector-Based RNAi Sales Market Share by Application (2016-2021) Table 60. Europe Vector-Based RNAi Sales by Application (2022-2027) & (K Units) Table 61. Europe Vector-Based RNAi Sales Market Share by Application (2022-2027) Table 62. China Vector-Based RNAi Sales (K Units) by Company (2016-2021) Table 63. China Vector-Based RNAi Sales Market Share by Company (2016-2021) Table 64. China Vector-Based RNAi Revenue by Company (2016-2021) & (US$ Million) Table 65. China Vector-Based RNAi Revenue Market Share by Company (2016-2021) Table 66. China Vector-Based RNAi Sales by Type (2016-2021) & (K Units) Table 67. China Vector-Based RNAi Sales Market Share by Type (2016-2021) Table 68. China Vector-Based RNAi Sales by Type (2022-2027) & (K Units) Table 69. China Vector-Based RNAi Sales Market Share by Type (2022-2027) Table 70. China Vector-Based RNAi Sales by Application (2016-2021) & (K Units) Table 71. China Vector-Based RNAi Sales Market Share by Application (2016-2021) Table 72. China Vector-Based RNAi Sales by Application (2022-2027) & (K Units) Table 73. China Vector-Based RNAi Sales Market Share by Application (2022-2027) Table 74. Japan Vector-Based RNAi Sales (K Units) by Company (2016-2021) Table 75. Japan Vector-Based RNAi Sales Market Share by Company (2016-2021) Table 76. Japan Vector-Based RNAi Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Vector-Based RNAi Revenue Market Share by Company (2016-2021) Table 78. Japan Vector-Based RNAi Sales by Type (2016-2021) & (K Units) Table 79. Japan Vector-Based RNAi Sales Market Share by Type (2016-2021) Table 80. Japan Vector-Based RNAi Sales by Type (2022-2027) & (K Units) Table 81. Japan Vector-Based RNAi Sales Market Share by Type (2022-2027) Table 82. Japan Vector-Based RNAi Sales by Application (2016-2021) & (K Units) Table 83. Japan Vector-Based RNAi Sales Market Share by Application (2016-2021) Table 84. Japan Vector-Based RNAi Sales by Application (2022-2027) & (K Units) Table 85. Japan Vector-Based RNAi Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Vector-Based RNAi Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Vector-Based RNAi Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Vector-Based RNAi Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Vector-Based RNAi Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Vector-Based RNAi Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Vector-Based RNAi Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Vector-Based RNAi Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Vector-Based RNAi Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Vector-Based RNAi Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Vector-Based RNAi Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Vector-Based RNAi Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Vector-Based RNAi Sales Market Share by Application (2022-2027) Table 98. India Vector-Based RNAi Sales (K Units) by Company (2016-2021) Table 99. India Vector-Based RNAi Sales Market Share by Company (2016-2021) Table 100. India Vector-Based RNAi Revenue by Company (2016-2021) & (US$ Million) Table 101. India Vector-Based RNAi Revenue Market Share by Company (2016-2021) Table 102. India Vector-Based RNAi Sales by Type (2016-2021) & (K Units) Table 103. India Vector-Based RNAi Sales Market Share by Type (2016-2021) Table 104. India Vector-Based RNAi Sales by Type (2022-2027) & (K Units) Table 105. India Vector-Based RNAi Sales Market Share by Type (2022-2027) Table 106. India Vector-Based RNAi Sales by Application (2016-2021) & (K Units) Table 107. India Vector-Based RNAi Sales Market Share by Application (2016-2021) Table 108. India Vector-Based RNAi Sales by Application (2022-2027) & (K Units) Table 109. India Vector-Based RNAi Sales Market Share by Application (2022-2027) Table 110. Merck & Co. Corporation Information Table 111. Merck & Co. Description and Business Overview Table 112. Merck & Co. Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 113. Merck & Co. Vector-Based RNAi Product Table 114. Merck & Co. Recent Development Table 115. Phio Pharmaceutical Corporation Information Table 116. Phio Pharmaceutical Description and Business Overview Table 117. Phio Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Phio Pharmaceutical Vector-Based RNAi Product Table 119. Phio Pharmaceutical Recent Development Table 120. Quark Pharmaceuticals Corporation Information Table 121. Quark Pharmaceuticals Description and Business Overview Table 122. Quark Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. Quark Pharmaceuticals Vector-Based RNAi Product Table 124. Quark Pharmaceuticals Recent Development Table 125. Thermo Fisher Scientific Corporation Information Table 126. Thermo Fisher Scientific Description and Business Overview Table 127. Thermo Fisher Scientific Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. Thermo Fisher Scientific Vector-Based RNAi Product Table 129. Thermo Fisher Scientific Recent Development Table 130. Silence Therapeutics Corporation Information Table 131. Silence Therapeutics Description and Business Overview Table 132. Silence Therapeutics Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. Silence Therapeutics Vector-Based RNAi Product Table 134. Silence Therapeutics Recent Development Table 135. Qiagen NV Corporation Information Table 136. Qiagen NV Description and Business Overview Table 137. Qiagen NV Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 138. Qiagen NV Vector-Based RNAi Product Table 139. Qiagen NV Recent Development Table 140. Ionis Pharmaceutical Corporation Information Table 141. Ionis Pharmaceutical Description and Business Overview Table 142. Ionis Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 143. Ionis Pharmaceutical Vector-Based RNAi Product Table 144. Ionis Pharmaceutical Recent Development Table 145. Dicerna Pharmaceuticals Corporation Information Table 146. Dicerna Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. Dicerna Pharmaceuticals Description and Business Overview Table 148. Dicerna Pharmaceuticals Vector-Based RNAi Product Table 149. Dicerna Pharmaceuticals Recent Development Table 150. Arrowhead Pharmaceuticals Corporation Information Table 151. Arrowhead Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Arrowhead Pharmaceuticals Description and Business Overview Table 153. Arrowhead Pharmaceuticals Vector-Based RNAi Product Table 154. Arrowhead Pharmaceuticals Recent Development Table 155. Arcturus Therapeutics Corporation Information Table 156. Arcturus Therapeutics Description and Business Overview Table 157. Arcturus Therapeutics Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 158. Arcturus Therapeutics Vector-Based RNAi Product Table 159. Arcturus Therapeutics Recent Development Table 160. Alnylam Pharmaceuticals Corporation Information Table 161. Alnylam Pharmaceuticals Description and Business Overview Table 162. Alnylam Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 163. Alnylam Pharmaceuticals Vector-Based RNAi Product Table 164. Alnylam Pharmaceuticals Recent Development Table 165. Production Base and Market Concentration Rate of Raw Material Table 166. Key Suppliers of Raw Materials Table 167. Vector-Based RNAi Distributors List Table 168. Vector-Based RNAi Customers List Table 169. Vector-Based RNAi Market Trends Table 170. Vector-Based RNAi Market Drivers Table 171. Vector-Based RNAi Market Challenges Table 172. Vector-Based RNAi Market Restraints Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Vector-Based RNAi Product Picture Figure 2. Global Vector-Based RNAi Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Vector-Based RNAi Sales Market Share by Application in 2021 & 2027 Figure 6. Hospitals Examples Figure 7. Speciality Clinics Examples Figure 8. Global Vector-Based RNAi Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Vector-Based RNAi Sales Growth Rate (2016-2027) & (US$ Million) Figure 10. Global Vector-Based RNAi Sales (K Units) Growth Rate (2016-2027) Figure 11. Global Vector-Based RNAi Price Trends Growth Rate (2016-2027) (US$/Unit) Figure 12. Global Vector-Based RNAi Revenue Market Share by Region: 2016 VS 2021 Figure 13. Global Vector-Based RNAi Revenue Market Share by Region: 2021 VS 2027 Figure 14. North America Vector-Based RNAi Revenue (Million USD) Growth Rate (2016-2027) Figure 15. North America Vector-Based RNAi Sales (K Units) Growth Rate (2016-2027) Figure 16. Europe Vector-Based RNAi Revenue (Million USD) Growth Rate (2016-2027) Figure 17. Europe Vector-Based RNAi Sales (Million USD) Growth Rate (2016-2027) Figure 18. China Vector-Based RNAi Revenue (Million USD) Growth Rate (2016-2027) Figure 19. China Vector-Based RNAi Sales (Million USD) and Growth Rate (2016-2027) Figure 20. Japan Vector-Based RNAi Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Japan Vector-Based RNAi Sales (Million USD) Growth Rate (2016-2027) Figure 22. Southeast Asia Vector-Based RNAi Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Vector-Based RNAi Sales (Million USD) Growth Rate (2016-2027) Figure 24. India Vector-Based RNAi Revenue (Million USD) Growth Rate (2016-2027) Figure 25. India Vector-Based RNAi Sales (Million USD) Growth Rate (2016-2027) Figure 26. Global 5 Largest Vector-Based RNAi Players Market Share by Revenue in Vector-Based RNAi: 2016 & 2020 Figure 27. Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Vector-Based RNAi Revenue Share by Type (2016-2021) Figure 29. Global Vector-Based RNAi Revenue Growth Rate by Type in 2016 & 2020 Figure 30. Global Vector-Based RNAi Revenue Share by Application (2016-2021) Figure 31. Global Vector-Based RNAi Revenue Growth Rate by Application in 2016 & 2020 Figure 32. North America Vector-Based RNAi Sales Market Share by Type in 2020 Figure 33. North America Vector-Based RNAi Sales Market Share by Application in 2020 Figure 34. Europe Vector-Based RNAi Sales Market Share by Type in 2020 Figure 35. Europe Vector-Based RNAi Sales Market Share by Application in 2020 Figure 36. China Vector-Based RNAi Sales Market Share by Type in 2020 Figure 37. China Vector-Based RNAi Sales Market Share by Application in 2020 Figure 38. Japan Vector-Based RNAi Sales Market Share by Type in 2020 Figure 39. Japan Vector-Based RNAi Sales Market Share by Application in 2020 Figure 40. Southeast Asia Vector-Based RNAi Sales Market Share by Type in 2020 Figure 41. Southeast Asia Vector-Based RNAi Sales Market Share by Application in 2020 Figure 42. India Vector-Based RNAi Sales Market Share by Type in 2020 Figure 43. India Vector-Based RNAi Sales Market Share by Application in 2020 Figure 44. Key Raw Materials Price Trend Figure 45. Manufacturing Cost Structure of Vector-Based RNAi Figure 46. Manufacturing Process Analysis of Vector-Based RNAi Figure 47. Vector-Based RNAi Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Merck & Co. Phio Pharmaceutical Quark Pharmaceuticals Thermo Fisher Scientific Silence Therapeutics Qiagen NV Ionis Pharmaceutical Dicerna Pharmaceuticals Arrowhead Pharmaceuticals Arcturus Therapeutics Alnylam Pharmaceuticals